1.Pathological characteristics and outcome of IgA nephropathy presented with nephrotic syndrome and its relationship with prognosis.
Niansheng YANG ; Qingqing WU ; Yong DU
Chinese Journal of Practical Internal Medicine 2002;0(08):-
Objective To study the pathological characteristics and outcomes of IgA nephropathy(IgAN)presented with nephrotic syndrome (NS) and its relationship with prognosis. Methods From 1987 to 2002,clinical and pathological characteristics of IgAN presented with NS and its response to glucocorticoids therapy were reviewed and compared to non-nephrotic group. Results 7 ^1%(51/723) of IgAN presented as NS.The prevalence of hypertension and renal insufficiency was significantly higher in nephrotic group than that of non-nephrotic group(35 ^3% vs 13 ^8% and 47 ^1% vs 19 ^2%, P
2.Determination of 6,7-Dehydroroyleanone in Salvia Deserta Schang by UV
Junmin CHANG ; Niansheng DU ; Qing WANG ; Jianhong MA ;
Chinese Traditional Patent Medicine 1992;0(08):-
Objective: To determin the content of 6,7 Dehydroroyleanone in Salvia deserta Schang. Methods: The content of 6.7 Delydroroyleanone were identified with TLC by UV.Results: The content was 0.37% and RSD was 2.6%. The average recovery was 98.3%.Conclusion: The method is simple and accurate.
3.Determination of acteoside isomer in Total Cistanches Glycosides Capsules by HPLC
Leihong ZHANG ; Yijun SONG ; Niansheng DU ; Qing WANG ;
Chinese Traditional Patent Medicine 1992;0(05):-
Objective:To establish a determination of acteoside isomer in Total Cistanchis Glycosides Capsules by HPLC.Methods: HPLC analysis was carried out on C 18 ODS column with acetonitrile——1.5% acetic acid as the mobile phase. The linear gradient of acetonitrile was from 11.5% to 20%(0-25min). The detection wavelength was 335nm. Results: The method was linear in the range of 0.2~1.0?g, r =0.9996. The average recovery was 98.85%, RSD was 1.51%( n =9). Conclusion:This method is simple, accurate, highly sensitive and reproducible. It may be used for the determination of acteoside isomer in Total Cistanchis Glycosides Capsules.
4.Application of TG-ROC analytical method in detection reagent quality evaluation
Jialiang DU ; You CHEN ; Jiamei GAO ; Yueyue LIU ; Yan LIU ; Xingliang FAN ; Qingchuan YU ; Niansheng TANG ; Tai GUO
International Journal of Laboratory Medicine 2016;37(17):2361-2363
Objective To compare the relationship between the enzyme‐linked immunosorbent assay(ELISA) reagent and West‐ern blot(WB) confirmation reagent for analyzing the quality lever of human T‐cell lymphotropic virus(HTLV) detection reagent . Methods The WB confirmation reagent was used to detect anti‐HTLV antibody in 156 human serum samples of ELISA prelimina‐ry screening positive .The ELISA cut‐off value(optimal value) was selected by using the two‐graph receiver operating characteristics (TG‐ROC) analytical method .The two‐by‐two table analysis was constructed to analyze the consistency of results detected by the two methods ,moreover the McNemar test was used to evaluate the consistency of detection results .The quality level of HTLV de‐tection reagent was comprehensively evaluated .Results Among 156 serum samples of ELISA preliminary screening positive ,only 40 samples were positive by the WB confirmation ,and other 116 samples were negative .The sensitivity and specificity of ELISA de‐tection reagent obtained by TG‐ROC analysis were 97 .5% and 45 .7% respectively ,the TG‐ROC test also indicated that the detec‐tion results had significant difference between ELISA and WB(P<0 .05) .By adjusting the cut‐off value ,the sensitivity and specific‐ity of ELISA were increased to 88 .8% (parametric method) .In the comparison of the parametric method and the non‐parametric method ,the obtained areas under the curve(AUC) was 0 .923 5(parametric method) ,their results were basically consistent .Conclu‐sion Although above results indicate that the detection results of ELISA reagent are different from those of WB ,but adjusting the cut off value can increase its sensitivity and specificity ,thus increases the reliability of diagnosis result .
5.Association of polymorphism of Fc receptor ? chain gene at position-29 in promoter with the susceptibility to systemic lupus erythematosus in southern Chinese
Shulu ZHOU ; Rengao YE ; Xiaobo LIU ; Hong ZHANG ; Hanshi XU ; Yong DU ; Youji LI ; Niansheng YANG ; Xiao YANG ; Xueqin YU
Chinese Journal of Pathophysiology 1989;0(06):-
AIM: To detect the association between the polymorphism of Fc receptor ? chain gene at position-29 in promoter and systemic lupus erythematosus(SLE). METHODS: The genotypes at position -29 in promoter of Fc receptor ? chain gene were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method in 180 patients with SLE and 140 ethnically matched controls in southern China. RESULTS: The frequencies of TT genotype(33.3%) and T allele (54 4%) at position -29 in patients with SLE were significantly higher than those in controls (17 9%, respectively), whereas, the frequencies of GG genotype (24 4%) and G allele (45 6%) in patients with SLE were remarkably lower than those in controls (31 4% and 57 1%, respectively) ( P 0 05) . CONCLUSION: Our results indicate that the T allele at position -29 in promoter of Fc receptor gene probably contributes to the susceptibility to SLE, but does not play a role in the occurrence of lupus nephritis.
6.Recommendations for the diagnosis and management of lupus nephritis in China
Hui ZHANG ; Niansheng YANG ; Jing LU ; Heng CAO ; Rong DU ; Wen ZHANG ; Yan ZHAO
Chinese Journal of Internal Medicine 2021;60(9):784-790
Lupus nephritis (LN) refers to renal involvement in systemic lupus erythematosus and is characterized by hematuria, proteinuria, edema, hypertension and renal insufficiency. The complete remission rate of proliferative LN remains low using the current induction protocols and LN tends to flare. Scientific and standardized diagnosis and therapy are crucial for the treatment of LN. Therefore, based on the current international and domestic experiences and guidelines, the Chinese Rheumatology Association developed the recommendations of diagnosis and therapy for LN, with the purpose of enhancing efficacy, reducing flare, halting renal progression and improving outcome of LN.